Is it ok for journalists to attend Bayer-funded training on new cancer treatments?
A patient’s perspective on recent prostate cancer screening news
Mayo spins rosy tale on Cologuard cancer screen — ignoring costs, false-positives and other crucial context
The hospital-media partnership: promoting public health or inducing public demand?
Journalists love superlative terms for cancer drugs – often questionably
Is 1 in 7 Odds a Breakthrough? Is it Even Promising?
Biden resurrects false promise of cancer “Moonshot”
What were main take-home messages of new ACS mammography guidelines?
Podcast: Pathologic profiling – Dr. Otis Brawley on cancer overdiagnosis
The Twitter health news hype machine